Please Wait.....
Report
Referral Management Market By Type (Inbound, Outbound) , By Deployment Mode (Cloud & Web-based, On-premise) By End User (Providers, Payers, Patients, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 325 Pages I Allied Market Research
Referral Management Market Expected to Garner $42.8 Billion by 2033, Growing at a CAGR of 17.4%
Abstract:The global referral management market is expected to grow primarily due to the growing focus on preventive care & early intervention. The North America region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global referral management market was valued at $8.6 billion in 2023 and is expected to register a revenue of $42.8 billion by 2033 at a CAGR of 17.4% during the forecast period 2024-2033.
Dynamics of the Market
The growing focus on patient-centric care models, increasing emphasis on data analytics & predictive modelling in healthcare, and the rising focus on preventive care & early intervention are expected to make the referral management market a highly profitable one in the forecast period. Besides, referral management allows patients to complete documentation at home, reducing in-office wait times and improving organizational efficiency.
However, according to market analysts, complexity of software and risk of errors & inaccuracies in automated referral processes might restrain the growth of the market.
Integration of AI & machine learning in healthcare processes and the rising need for solutions addressing referral leakage & network optimization present significant opportunities for referral management market growth. Moreover, effective communication about eConsults and automated referral processes can build trust, improve patient engagement, and increase satisfaction.
Key Players of the Market
The major players of the referral management market include GetWellNetwork, CarePort Health, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Cerner Corporation, Athena Health, Eceptionist, Inc., and eHealth Technologies, Inc.
What the Report Covers
In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter's five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Consumer Buying Behavior Analysis
- End user preferences and pain points
- Investment Opportunities
- Upcoming/New Entrant by Regions
- Technology Trend Analysis
- Consumer Preference and Product Specifications
- Go To Market Strategy
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Pain Point Analysis
- Regulatory Guidelines
- Strategic Recommendations
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- Market share analysis of players at global/region/country level
- SWOT Analysis
Key Market Segments
By Type
- Inbound
- Outbound
By Deployment Mode
- Cloud Web-based
- On-premise
By End User
- Providers
- Payers
- Patients
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- Spain
- UK
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA
- Key Market Players
- GetWellNetwork
- EPIC Systems Corporation
- Careport Health
- Allscripts Healthcare Solutions, Inc.,
- Athena Health
- Cerner Corporation
- Eceptionist, Inc.
- eHealth Technologies, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: IMMUNOLOGY MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Diagnostic Testing Equipment
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Biomarkers
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Biopharmaceuticals
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNOLOGY MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Allergy And Hypersensitivity
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Autoimmune Disease
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Infectious Disease
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. HIV And AIDS
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNOLOGY MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Pharmaceutical And Biotechnology Companies
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Diagnostic Laboratories
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNOLOGY MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Immunology Market
7.2.6.1. Market Size and Forecast, By Product Type
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Immunology Market
7.2.7.1. Market Size and Forecast, By Product Type
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Immunology Market
7.2.8.1. Market Size and Forecast, By Product Type
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Immunology Market
7.3.6.1. Market Size and Forecast, By Product Type
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Immunology Market
7.3.7.1. Market Size and Forecast, By Product Type
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Immunology Market
7.3.8.1. Market Size and Forecast, By Product Type
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Immunology Market
7.3.9.1. Market Size and Forecast, By Product Type
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Immunology Market
7.3.10.1. Market Size and Forecast, By Product Type
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Immunology Market
7.3.11.1. Market Size and Forecast, By Product Type
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Immunology Market
7.4.6.1. Market Size and Forecast, By Product Type
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Immunology Market
7.4.7.1. Market Size and Forecast, By Product Type
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Immunology Market
7.4.8.1. Market Size and Forecast, By Product Type
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Immunology Market
7.4.9.1. Market Size and Forecast, By Product Type
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Immunology Market
7.4.10.1. Market Size and Forecast, By Product Type
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Immunology Market
7.4.11.1. Market Size and Forecast, By Product Type
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Immunology Market
7.5.6.1. Market Size and Forecast, By Product Type
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Immunology Market
7.5.7.1. Market Size and Forecast, By Product Type
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Immunology Market
7.5.8.1. Market Size and Forecast, By Product Type
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Immunology Market
7.5.9.1. Market Size and Forecast, By Product Type
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. AbbVie Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Johnson And Johnson
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Pfizer Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Novartis AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Merck And Co., Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Bristol-Myers Squibb Company
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Amgen Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Eli Lilly And Company
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Gilead Sciences, Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Sanofi
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. REFERRAL MANAGEMENT MARKET FOR INBOUND, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. REFERRAL MANAGEMENT MARKET FOR OUTBOUND, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 5. REFERRAL MANAGEMENT MARKET FOR CLOUD WEB-BASED, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. REFERRAL MANAGEMENT MARKET FOR ON-PREMISE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 8. REFERRAL MANAGEMENT MARKET FOR PROVIDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. REFERRAL MANAGEMENT MARKET FOR PAYERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. REFERRAL MANAGEMENT MARKET FOR PATIENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. REFERRAL MANAGEMENT MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. REFERRAL MANAGEMENT MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA REFERRAL MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. U.S. REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 18. U.S. REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 19. U.S. REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. CANADA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 21. CANADA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 22. CANADA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE REFERRAL MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. GERMANY REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 31. GERMANY REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. ITALY REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 34. ITALY REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 35. ITALY REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. SPAIN REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 37. SPAIN REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 38. SPAIN REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. UK REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 40. UK REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 41. UK REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. FRANCE REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 43. FRANCE REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 44. FRANCE REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. CHINA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 53. CHINA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 54. CHINA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. INDIA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 59. INDIA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 60. INDIA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. SOUTH KOREA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 63. SOUTH KOREA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. AUSTRALIA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 66. AUSTRALIA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA REFERRAL MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 77. SAUDI ARABIA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 78. SAUDI ARABIA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 80. UAE REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 81. UAE REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 82. UAE REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH AFRICA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 84. SOUTH AFRICA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 85. SOUTH AFRICA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA REFERRAL MANAGEMENT MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 87. REST OF LAMEA REFERRAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2024 - 2033 ($BILLION)
TABLE 88. REST OF LAMEA REFERRAL MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 89. GETWELLNETWORK: KEY EXECUTIVES
TABLE 90. GETWELLNETWORK: COMPANY SNAPSHOT
TABLE 91. GETWELLNETWORK: OPERATING SEGMENTS
TABLE 92. GETWELLNETWORK: PRODUCT PORTFOLIO
TABLE 93. GETWELLNETWORK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 95. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 96. EPIC SYSTEMS CORPORATION: OPERATING SEGMENTS
TABLE 97. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 98. EPIC SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. CAREPORT HEALTH: KEY EXECUTIVES
TABLE 100. CAREPORT HEALTH: COMPANY SNAPSHOT
TABLE 101. CAREPORT HEALTH: OPERATING SEGMENTS
TABLE 102. CAREPORT HEALTH: PRODUCT PORTFOLIO
TABLE 103. CAREPORT HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : KEY EXECUTIVES
TABLE 105. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : COMPANY SNAPSHOT
TABLE 106. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : OPERATING SEGMENTS
TABLE 107. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : PRODUCT PORTFOLIO
TABLE 108. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. ATHENA HEALTH: KEY EXECUTIVES
TABLE 110. ATHENA HEALTH: COMPANY SNAPSHOT
TABLE 111. ATHENA HEALTH: OPERATING SEGMENTS
TABLE 112. ATHENA HEALTH: PRODUCT PORTFOLIO
TABLE 113. ATHENA HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. CERNER CORPORATION: KEY EXECUTIVES
TABLE 115. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 116. CERNER CORPORATION: OPERATING SEGMENTS
TABLE 117. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 118. CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119. ECEPTIONIST, INC.: KEY EXECUTIVES
TABLE 120. ECEPTIONIST, INC.: COMPANY SNAPSHOT
TABLE 121. ECEPTIONIST, INC.: OPERATING SEGMENTS
TABLE 122. ECEPTIONIST, INC.: PRODUCT PORTFOLIO
TABLE 123. ECEPTIONIST, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124. EHEALTH TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 125. EHEALTH TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 126. EHEALTH TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 127. EHEALTH TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 128. EHEALTH TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL REFERRAL MANAGEMENT MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF REFERRAL MANAGEMENT MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN REFERRAL MANAGEMENT MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALREFERRAL MANAGEMENT MARKET
FIGURE 10. GLOBAL REFERRAL MANAGEMENT MARKET SEGMENTATION, BY TYPE
FIGURE 11. REFERRAL MANAGEMENT MARKET FOR INBOUND, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. REFERRAL MANAGEMENT MARKET FOR OUTBOUND, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL REFERRAL MANAGEMENT MARKET SEGMENTATION, BY DEPLOYMENT MODE
FIGURE 14. REFERRAL MANAGEMENT MARKET FOR CLOUD WEB-BASED, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. REFERRAL MANAGEMENT MARKET FOR ON-PREMISE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL REFERRAL MANAGEMENT MARKET SEGMENTATION, BY END USER
FIGURE 17. REFERRAL MANAGEMENT MARKET FOR PROVIDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. REFERRAL MANAGEMENT MARKET FOR PAYERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. REFERRAL MANAGEMENT MARKET FOR PATIENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. REFERRAL MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: REFERRAL MANAGEMENT MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. GETWELLNETWORK: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. GETWELLNETWORK: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. GETWELLNETWORK: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. EPIC SYSTEMS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. EPIC SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. EPIC SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. CAREPORT HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. CAREPORT HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. CAREPORT HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : NET SALES, 2021-2023 ($BILLION)
FIGURE 38. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. ATHENA HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. ATHENA HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. ATHENA HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. CERNER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. CERNER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. CERNER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. ECEPTIONIST, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. ECEPTIONIST, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. ECEPTIONIST, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. EHEALTH TECHNOLOGIES, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. EHEALTH TECHNOLOGIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. EHEALTH TECHNOLOGIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security